Quick Answer
OptimizeRx Corp reported Net Income Loss of $5.13 million for the year ending 2025.
- OptimizeRx Corp showed an increase of +125.5% in Net Income Loss from 2024 to 2025.
- This data is from OptimizeRx Corp's annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 15 years of available data (2011 to 2025), OptimizeRx Corp's Net Income Loss has grown by 342.0%.
- Historical annual values: Fiscal year 2025: $5.13 million | Fiscal year 2024: -$20.11 million | Fiscal year 2023: -$17.57 million | Fiscal year 2022: -$11.44 million | Fiscal year 2021: $378.1 thousand | Fiscal year 2020: -$2.21 million | Fiscal year 2019: -$3.14 million | Fiscal year 2018: $226.3 thousand | Fiscal year 2017: -$2.10 million | Fiscal year 2016: -$1.54 million | Fiscal year 2015: -$595.1 thousand | Fiscal year 2014: -$1.03 million | Fiscal year 2013: -$267.3 thousand | Fiscal year 2012: -$454.6 thousand | Fiscal year 2011: -$2.12 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: